Andreakos E, Brian F, Marc F (2004) ‘Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation?‘, Immunological reviews, 202: 250– 65
Batstone G, Doble A, JSH G (2002) Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS). Clin Experimental Immunol 128:302–307
Benson J, Carl S (1992) Cytomegalovirus prostatitis. Urology 40:165–167
Article PubMed CAS Google Scholar
Cao Y, Yijie C, Awais I, Farhan K, Dianyou X, Xingxing C, Wenlu W, Xiaohui Z (2019) A nanoparticle-coupled T2 peptide induces immune tolerance and ameliorates chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in mice model. Fundam Clin Pharmacol 33:267–276
Article PubMed CAS Google Scholar
Cheng Y, Yanfang C, Awais I, Farhan K, Xue L, Dianyou X, Xingxing C, Wenlu W, Ziwei L, Cunyu L (2019) Novel treatment of experimental autoimmune prostatitis by nanoparticle-conjugated autoantigen peptide T2. Inflammation 42:1071–1081
Article PubMed CAS Google Scholar
Collins M, Randall S, Michael MICHAELP B (1998) How common is prostatitis? A national survey of physician visits. J Urol 159:1224–1228
Article PubMed CAS Google Scholar
Firestein S, WD X, Townsend K, JOSE DAVIDB, ANDREW A, NATHAN G Z (1988) Cytokines in chronic inflammatory arthritis. I. failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 168:1573–1586
Article PubMed CAS Google Scholar
Habermacher M, Judd C, Anthony S (2006) Prostatitis/chronic pelvic pain syndrome. Annu Rev Med 57:195–206
Article PubMed CAS Google Scholar
Jijon H, Allard B, Jobin B (2004) NF-κB inducing kinase activates NF-κB transcriptional activity independently of IκB kinase γ through a p38 MAPK-dependent RelA phosphorylation pathway. Cell Signal 16:1023–1032
Article PubMed CAS Google Scholar
Keetch W, Peter H, Timothy R (1994) Development of a mouse model for nonbacterial prostatitis. J Urol 152:247–250
Article PubMed CAS Google Scholar
Khan U, Awais I, Waqas N, Muhammad K, Mengqi Y, Gang W, Xiaoqian L, Lei H, Xiaohui Z (2017) A novel mouse model of chronic prostatitis/chronic pelvic pain syndrome induced by immunization of special peptide fragment with aluminum hydroxide adjuvant. Immunol Lett 187:61–67
Kouiavskaia V, Scott S, Carla B, Elena N, Richard A (2009) T-cell recognition of prostatic peptides in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 182:2483–2489
Article PubMed PubMed Central CAS Google Scholar
Ku J, Jae-Seung P, Soo‐Woong K (2005) Chronic prostatitis in Korea: a nationwide postal survey of practicing urologists in 2004. Asian J Androl 7:427–432
Liu J, Xiaoyue H, Tingyue Z, Keyue T, Zhaoping L, Feng L (2023) Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy. J Hematol Oncol 16:116
Article PubMed PubMed Central CAS Google Scholar
Ludwig M, Steltz C, Huwe P, Schäffer R, Altmannsberger M, Weidner W (2001) Immunocytological analysis of leukocyte subpopulations in urine specimens before and after prostatic massage. Eur Urol 39:277–282
Article PubMed CAS Google Scholar
Maaliki D, Aneese J, Suzanne N, Amirhossein S, Ali E (2024) ‘Adrenoceptor Desensitization: Current understanding of mechanisms’, Pharmacological Reviews, 76: 358– 87
Murphy F, Anthony S, Praveen T (2014) Immune mediators of chronic pelvic pain syndrome. Nat Reviews Urol 11:259
Rivero E, Catherine C, Mirtha D, Clelia R, Claude C (1998) Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). J Autoimmun 11:603–610
Article PubMed CAS Google Scholar
Roberts O, Michael L, Thomas R, Cynthia G, David B, Steven J (1998) ‘Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men’, Urology, 51: 578– 84
Schaeffer J, Wolfgang W, George B, Henri B, Truls J, Werner H, John K, Bernard L, Kurt N, Curtis N (2003) Summary consensus statement: diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol Supplements 2:1–4
Tang M, Rahat U, Junaid W, Farhan K, Awais I, Xingxing C, Wenlu W, Min H, Yuqian L, Xiaohui Z (2019) Effect of oral T2 Antigen on Chronic Prostatitis/Chronic Pelvic Pain Syndrome in mice Model. Inflammation 42:2086–2094
Article PubMed CAS Google Scholar
Thakkinstian A, John A, Thunyarat A, Curtis N (2012) α-blockers, antibiotics and anti‐inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int 110:1014–1022
Article PubMed CAS Google Scholar
Tyagi P, Mahendra K, Subrata P, Zhou W, Naoki Y (2015) Mp25-07 prostatic inflammation evokes upregulation of neurotrophins in sensory ganglia: possible contribution to dysfunctional voiding. J Urol 193:e287–e87
Wang W, Muhammad N, Mirza B, Muhammad A, Zhou X (2018) Experimental rodent models of chronic prostatitis and evaluation criteria. Biomed Pharmacother 108:1894–1901
Wang W, Muhammad N, Fatima M, Xingxing C, Awais I, Ziwei L, Hafiz Z, Meng T, Muhammad S, Zhou X (2019) ‘Morphological reseach on expression of inflammatory mediators in murine models of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by T2 antigen’, Andrologia
Wenninger K, Julia H, Ivan R, James B, Richard B (1996) Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 155:965–968
Comments (0)